News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genzyme Corporation (GENZ) Convenes 1st International Gaucher Conference on Bone Disease



7/1/2013 7:06:34 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the first international meeting focused on bone disease in patients with Gaucher disease will take place July 5 and 6 in Rio de Janeiro, Brazil. This meeting will bring together over 100 physicians and researchers from around the world, with the goal of improving clinical care and shaping the future direction of research specific to bone disease.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES